Barinthus Biotherapeutics plc. Quarterly Operating Margin in % from Q4 2020 to Q3 2024

Taxonomy & unit: ratio: %
Description: The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary: Barinthus Biotherapeutics plc. quarterly/annual Operating Margin history and growth rate from Q4 2020 to Q3 2024.
Barinthus Biotherapeutics plc. Operating Margin for the quarter ending September 30, 2024 was -431 %, a 64.9% increase year-over-year.
Barinthus Biotherapeutics plc. annual Operating Margin for 2023 was -10.5K %, a 115646% decline from 2022.
Barinthus Biotherapeutics plc. annual Operating Margin for 2022 was -9.04 %, a 99.9% increase from 2021.
Barinthus Biotherapeutics plc. annual Operating Margin for 2021 was -16.9K %, a 3958% decline from 2020.

Operating Margin, Quarterly (%)

Operating Margin, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date
Q3 2024	-431	+796	+64.9%	Jul 1, 2024	Sep 30, 2024
Q1 2024	-23.8K	-23.7K	-27262%	Jan 1, 2024	Mar 31, 2024
Q4 2023	-10.5K	-10.5K	-115646%	Oct 1, 2023	Dec 31, 2023
Q3 2023	-1.23K	-1.24K	-10632%	Jul 1, 2023	Sep 30, 2023
Q2 2023	-490	-464	-1791%	Apr 1, 2023	Jun 30, 2023
Q1 2023	-86.8	+168	+65.9%	Jan 1, 2023	Mar 31, 2023
Q4 2022	-9.04	+16.9K	+99.9%	Oct 1, 2022	Dec 31, 2022
Q3 2022	11.7	+6.14K		Jul 1, 2022	Sep 30, 2022
Q2 2022	-25.9	+858	+97.1%	Apr 1, 2022	Jun 30, 2022
Q1 2022	-255	+243	+48.8%	Jan 1, 2022	Mar 31, 2022
Q4 2021	-16.9K	-16.5K	-3958%	Oct 1, 2021	Dec 31, 2021
Q3 2021	-6.13K			Jul 1, 2021	Sep 30, 2021
Q2 2021	-884			Apr 1, 2021	Jun 30, 2021
Q1 2021	-498			Jan 1, 2021	Mar 31, 2021
Q4 2020	-416			Oct 1, 2020	Dec 31, 2020

* An asterisk sign (*) next to the value indicates that the value is likely invalid.